Latest total revenue for THTX: $84M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of May 2025
Trailing 12 months ending May 2025
Theratechnologies (THTX) currently reports a total revenue of $84M as of May 2025. That compares with $82M in the prior-year period — up 2.4% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Theratechnologies's total revenue history and peer comparisons.
Theratechnologies's total revenue increased from $82M to $84M — a 2.4% year-over-year increase (period ending May 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Theratechnologies's total revenue of $84M is lower than the Healthcare sector average of $110B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Theratechnologies reported $84M in total revenue as of May 2025. That compares with $82M in the prior-year period — up 2.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total revenue of $84M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Theratechnologies, and consider following THTX for alerts when major investors trade the stock.